4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NeoGenomics, Inc. (NEO) operates in the Diagnostics & Research industry and is headquartered in Fort Myers, United States with about 2,500 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, NEO reported $727M in revenue and ($108M) in net income.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.
Interactive charts & full statements → Open the NEO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $727M | $661M | $592M | $510M | — |
| Gross Profit | $314M | $290M | $245M | $188M | — |
| Operating Income (EBIT) | ($88M) | ($85M) | ($97M) | ($153M) | — |
| Net Income | ($108M) | ($79M) | ($88M) | ($144M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $187M | $190M | $188M | $181M | $168M | — |
| Gross Profit | $81M | $83M | $80M | $77M | $73M | — |
| Operating Income (EBIT) | ($18M) | ($13M) | ($20M) | ($28M) | ($28M) | — |
| Net Income | ($17M) | ($10M) | ($27M) | ($45M) | ($26M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.6B | $1.7B | $1.7B | — |
| Total Liabilities | $523M | $736M | $740M | $742M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NEO viewer.
About TickerBase · Data methodology & sources